Literature DB >> 11564377

Rheumatic fever.

E Rullan1, L H Sigal.   

Abstract

Rheumatic fever is a multisystem inflammatory disease that occurs as a delayed sequel to group A streptococcal pharyngitis. It is less common than it was 50 years ago but is still a major cause of heart disease in developing areas of the world. The relationship between the site of infection, the type of causative organism, and susceptibility of the host is essential in the development of the disease. Its major clinical manifestations include carditis, migratory polyarthritis, chorea, erythema marginatum, and subcutaneous nodules. It can manifest as an acute febrile illness consisting of migratory polyarthritis involving the large joints, as carditis and valvulitis, or as Sydenham's chorea with involvement of the central nervous system. The disorder in its milder form resolves itself without sequelae. Carditis is the condition most associated with increased mortality and morbidity and may be fatal in its severe forms. Penicillin is the most appropriate primary and secondary prophylaxis. Anti- inflammatory agents provide symptomatic relief but do not prevent rheumatic heart disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564377     DOI: 10.1007/s11926-996-0016-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  38 in total

1.  Diagnosis of active rheumatic carditis. The echoes of change.

Authors:  J Narula; Y Chandrasekhar; S Rahimtoola
Journal:  Circulation       Date:  1999-10-05       Impact factor: 29.690

2.  Acute rheumatic fever: diagnosis and treatment.

Authors:  K Alsaeid; H A Majeed
Journal:  Pediatr Ann       Date:  1998-05       Impact factor: 1.132

3.  Can class I epitope of M protein be a diagnostic marker for rheumatic fever in populations endemic for group A streptococci?

Authors:  E R Brandt; B Currie; L Mammo; S Pruksakorn; M F Good
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

Review 4.  Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America.

Authors:  A L Bisno; M A Gerber; J M Gwaltney; E L Kaplan; R H Schwartz
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

5.  Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients.

Authors:  A Bhatnagar; A Grover; N K Ganguly
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

6.  The treatment of rheumatic carditis: a review and meta-analysis.

Authors:  D A Albert; L Harel; T Karrison
Journal:  Medicine (Baltimore)       Date:  1995-01       Impact factor: 1.889

Review 7.  Polyarthritis and fever.

Authors:  R S Pinals
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

8.  Poststreptococcal reactive rheumatic syndrome.

Authors:  A Schattner
Journal:  J Rheumatol       Date:  1996-07       Impact factor: 4.666

9.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association.

Authors: 
Journal:  JAMA       Date:  1992-10-21       Impact factor: 56.272

10.  Rheumatic fever and the HLA complex. A cosegregation study.

Authors:  M Gerbase-DeLima; L C Scala; J Temin; D V Santos; P A Otto
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

View more
  9 in total

1.  Henoch-Schönlein purpura: a case with atypical presentation.

Authors:  Mukaddes Kalyoncu; Murat Cakir; Erol Erduran; Aysenur Okten
Journal:  Rheumatol Int       Date:  2005-09-23       Impact factor: 2.631

Review 2.  Cutting edge issues in rheumatic fever.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

3.  Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-kappaB activation.

Authors:  Hidekatsu Iha; Jean-Marie Peloponese; Lynn Verstrepen; Grzegorz Zapart; Fumiyo Ikeda; C Dahlem Smith; Matthew F Starost; Venkat Yedavalli; Karen Heyninck; Ivan Dikic; Rudi Beyaert; Kuan-Teh Jeang
Journal:  EMBO J       Date:  2008-01-31       Impact factor: 11.598

4.  Substance P is required for the pathogenesis of EMCV infection in mice.

Authors:  Prema Robinson; Armandina Garza; Jeffrey Moore; T Kris Eckols; Skakun Parti; Vishwanathan Balaji; Jesus Vallejo; David J Tweardy
Journal:  Int J Clin Exp Med       Date:  2009-03-31

Review 5.  Update on acute rheumatic fever: it still exists in remote communities.

Authors:  Sharen Madden; Len Kelly
Journal:  Can Fam Physician       Date:  2009-05       Impact factor: 3.275

6.  Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly.

Authors:  Gretchen J Mahler; Jonathan T Butcher
Journal:  Int J Inflam       Date:  2011-07-18

7.  Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis.

Authors:  Katharine A Robertson; Jimmy A Volmink; Bongani M Mayosi
Journal:  BMC Cardiovasc Disord       Date:  2005-05-31       Impact factor: 2.298

8.  Substance P receptor antagonism: a potential novel treatment option for viral-myocarditis.

Authors:  Prema Robinson; George E Taffet; Nikita Engineer; Mitra Khumbatta; Bahrom Firozgary; Corey Reynolds; Thuy Pham; Tushar Bulsara; Gohar Firozgary
Journal:  Biomed Res Int       Date:  2015-03-02       Impact factor: 3.411

9.  A Case of Acute Rheumatic Fever With Henoch Schonlein Purpura.

Authors:  Ozlem Bostan Gayret; Meltem Erol; Ozgul Yigit; Emine Kutanis; Sinan Yavuz; Ali Muhammedoglu; Ozgur Kasapcopur
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.